retatrutide new zealand 20 mg/3mL – My Store Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist

Higher-strength vials keep injection volumes practical

Clinical trials have identified higher risks of gastrointestinal (GI) events such as pancreatitis, bowel obstruction, biliary disease, and gastroparesis

JCI Insight 8:e170671 Delvadia P, Dhote V, Mandloi AS et al (2025) Dual GLP-1 and GIP agonist Tirzepatide exerted neuroprotective action in a parkinsons disease rat model

Weeks 9 through 12 (second escalation): Another dose increase, still once daily

Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists = antagonists

Yes, especially during the first 4 to 8 weeks when calorie intake drops significantly and the body has not yet adapted to lower energy availability